SPY329.15+2.63 0.81%
DIA266.70+2.35 0.89%
IXIC10,895.06+149.79 1.39%

Oppenheimer Maintains Outperform on Neurocrine Biosciences, Raises Price Target to $132

Oppenheimer maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Outperform and raises the price target from $115 to $132.

Benzinga · -

Oppenheimer maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Outperform and raises the price target from $115 to $132.